Literature DB >> 6365654

Changing patterns of fibronectin, laminin, type IV collagen, and a basement membrane proteoglycan during rat Mullerian duct regression.

H Ikawa, R L Trelstad, J M Hutson, T F Manganaro, P K Donahoe.   

Abstract

Antibodies to type IV collagen, laminin, heparan sulfate proteoglycan, and fibronectin were used to study the regression of the rat Mullerian duct. All four of these matrix constituents are located at the perimeter of the Mullerian duct within the ductal basement membrane. As the Mullerian duct regresses, the staining of all of these basement membrane constituents becomes irregular and discontinuous. Fibronectin, which is also present in the interstitium, becomes undetectable in the mesenchyme which condenses around the regressing Mullerian duct. These data indicate that degradation of the extracellular matrix around the male Mullerian duct is a central event in the regression of this structure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365654     DOI: 10.1016/0012-1606(84)90190-8

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  9 in total

Review 1.  Angiostatic steroids. Method of discovery and mechanism of action.

Authors:  J Folkman; D E Ingber
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

Review 2.  Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.

Authors:  David T MacLaughlin; Patricia K Donahoe
Journal:  Future Oncol       Date:  2010-03       Impact factor: 3.404

Review 3.  Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression.

Authors:  Richard L Cate
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

4.  Ultrastructural localization of type IV collagen and laminin in the seven-day-old mouse embryo.

Authors:  R Herken; H J Barrach
Journal:  Anat Embryol (Berl)       Date:  1985

5.  Lectin bindings and diethylstilbestrol effects on the recognition of mullerian inhibiting substance (MIS) on chick mullerian ducts by MIS-antiserum.

Authors:  J J Wang; C S Yin; C S Teng
Journal:  Histochemistry       Date:  1990

6.  Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct.

Authors:  Akihiro Fujino; Nelson A Arango; Yong Zhan; Thomas F Manganaro; Xianlin Li; David T MacLaughlin; Patricia K Donahoe
Journal:  Dev Biol       Date:  2008-11-05       Impact factor: 3.582

7.  Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.

Authors:  G D Orvis; S P Jamin; K M Kwan; Y Mishina; V M Kaartinen; S Huang; A B Roberts; L Umans; D Huylebroeck; A Zwijsen; D Wang; J F Martin; R R Behringer
Journal:  Biol Reprod       Date:  2008-03-05       Impact factor: 4.285

Review 8.  Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors.

Authors:  Jang Heub Kim; David T MacLaughlin; Patricia K Donahoe
Journal:  Obstet Gynecol Sci       Date:  2014-09-17

9.  In vivo manipulation of the extracellular matrix induces vascular regression in a basal chordate.

Authors:  Delany Rodriguez; Brian P Braden; Scott W Boyer; Daryl A Taketa; Leah Setar; Chris Calhoun; Alessandro Di Maio; Adam Langenbacher; Megan T Valentine; Anthony W De Tomaso
Journal:  Mol Biol Cell       Date:  2017-06-14       Impact factor: 4.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.